Morehouse–Tuskegee–UAB cancer partnership to reduce disparities

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

NIH-funded research Morehouse School of Medicine · NIH-11191396

Teams at Morehouse, Tuskegee, and UAB are working together to learn why cancer outcomes differ in the Southeast and to help patients in underserved communities get better care.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMorehouse School of Medicine NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11191396 on NIH RePORTER

What this research studies

This partnership brings together clinicians, researchers, and community outreach teams at Morehouse School of Medicine, Tuskegee University, and the UAB O'Neal Comprehensive Cancer Center to tackle cancer disparities in the Southeast. It funds shared cores for administration, outreach, bioethics, and biostatistics/bioinformatics and supports multiple pilot and full research projects, including work on tumor cell density and gene expression in breast cancer. The program also builds training and career pathways for new cancer investigators at Morehouse and Tuskegee and links research with community education and engagement. As a patient in the region, you may be invited to participate in pilot studies, provide samples, or join outreach and education activities.

Who could benefit from this research

Good fit: Ideal candidates are people with cancer who receive care in the Southeast—particularly patients treated near Atlanta, Tuskegee, or Birmingham and those from underserved or minority communities, including breast cancer patients for some pilots.

Not a fit: Patients who live outside the region, those without cancer, or those whose cancer type is not included in a pilot project are unlikely to receive direct benefit from this grant.

Why it matters

Potential benefit: If successful, the partnership could clarify drivers of cancer disparities and lead to better tests, treatments, and access to care for underserved patients.

How similar studies have performed: Other U54 partnership programs have successfully strengthened research teams, community outreach, and pilot discoveries, although some projects here pursue novel scientific questions.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.